Schrodinger stock earned a positive adjustment to its Relative Strength (RS) Rating, from 66 to 73. Please watch the video at ...

Not all fiber is created equal when it comes to gut issues. Certain fiber types can provoke symptoms, while others aid in ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

Older adults with moderate to severe IBD can achieve remission with JAK inhibitors, according to a study presented at Crohn’s & Colitis Congress.

Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.

40,997 people played the daily Crossword recently. Can you solve it faster than others?40,997 people played the daily ...

A new era at IBD began nearly a year ago with the launch of MarketSurge, a makeover of the MarketSmith charting and research ...

and 120,338 matched individuals without IBD. The researchers found that during a mean follow-up of 10.5 years, 1.9% of ...

Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...

In response to these issues, this study implemented an interdisciplinary approach wherein a team comprising medical and pharmaceutical professionals conducted a comprehensive survey coupled with a ...